Studies on naturally-occurring CDKN1B mutations will help us understand the link between p27 and neuroendocrine tumor predisposition, a prerequisite to offer in the future personalized care to the families carrying such mutations. The gene discussed is CDKN1B; the disease is neuroendocrine neoplasm.